DCF — LAC OLIVE VIEW/UCLA MEDICAL CENTER
Enterprise Value: $-1.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.2B
Enterprise Value
$-393.8M
PV of Cash Flows
$-851.1M
PV of Terminal Value
$-1.4B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $777.6M | $-77.6M | -10.0% | $-110.5M | $-100.5M |
| Year 2 | $800.9M | $-71.9M | -9.0% | $-105.8M | $-87.4M |
| Year 3 | $824.9M | $-65.8M | -8.0% | $-100.7M | $-75.7M |
| Year 4 | $849.7M | $-63.5M | -7.0% | $-99.5M | $-68.0M |
| Year 5 | $875.2M | $-63.3M | -7.0% | $-100.3M | $-62.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$754.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10477453743758307
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5